Skip to main content

GTX Sef receives CFTC approval

Registration go-ahead replaces temporary nod from US regulators

Green light
Green light: GTX Sef receives permanent approval from the CFTC

Institutional foreign exchange trading platform GTX has gained approval from the US Commodity Futures Trading Commission (CFTC) to register its swap execution facility (Sef) for Dodd-Frank compliant trading of non-deliverable forwards (NDFs) and swaps.

The go-ahead replaces the temporary registration status granted in April 2014, which enabled the venue to offer clients the ability to trade NDF contracts under US regulatory requirements.

"We launched the Sef two years ago to support asset managers seeking to trade NDFs in a fully-compliant manner," said Vincent Sangiovanni, chief executive of GTX. "We expect it to grow in importance as regulations on foreign exchange are implemented by regulators in the US and elsewhere."

Enabling institutional traders to trade any FX product 24 hours a day when the markets are open
GTX

The GTX Sef operates a central limit order book for NDF trading, as well as request-for-quote and request-for-stream options. GTX also provides agency execution services through its registered swap-dealer entity for NDFs and all FX products in G10 and emerging market currencies.

"These platforms and services, together with GTX's flagship ECN, form a complete ecosystem, enabling institutional traders to trade any FX product 24 hours a day when the markets are open," the company said in a press release.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@fx-markets.com or view our subscription options here: https://subscriptions.fx-markets.com

You are currently unable to copy this content. Please contact info@fx-markets.com to find out more.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a FX Markets account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: